PBRM1 and BAP1 expression in renal cell carcinoma

被引:0
|
作者
Kuthi, L. [1 ]
Fallmann, E. [1 ]
Jenei, A. [1 ]
Posfai, B. [1 ]
Maraz, A. [1 ]
机构
[1] Univ Szeged, Dept Pathol, Szeged, Hungary
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
OFP-13-010
引用
收藏
页码:S44 / S44
页数:1
相关论文
共 50 条
  • [21] Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma
    Wang, Zhun
    Peng, Shuanghe
    Guo, Linpei
    Xie, Hui
    Wang, Aixiang
    Shang, Zhiqun
    Niu, Yuanjien
    CLINICA CHIMICA ACTA, 2018, 486 : 9 - 17
  • [22] PBRM1 but not BAP1 deficiency is a frequent feature of multifocal non-cystic low-grade clear cell renal cell carcinoma
    Agaimy, Abbas
    Trpkov, Kiril
    Gao, Yuan
    Hartmann, Arndt
    Hes, Ondrej
    LABORATORY INVESTIGATION, 2019, 99
  • [23] PBRM1 but not BAP1 deficiency is a frequent feature of multifocal non-cystic low-grade clear cell renal cell carcinoma
    Agaimy, Abbas
    Trpkov, Kiril
    Gao, Yuan
    Hartmann, Arndt
    Hes, Ondrej
    MODERN PATHOLOGY, 2019, 32
  • [24] Expression of Bap1 in Clear Cell Renal Cell Carcinoma
    Fatima, Arooj
    JOURNAL OF PATHOLOGY, 2024, 264 : S12 - S12
  • [25] BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies
    Piva, Francesco
    Santoni, Matteo
    Matrana, Marc R.
    Satti, Suma
    Giulietti, Matteo
    Occhipinti, Giulia
    Massari, Francesco
    Cheng, Liang
    AntonioLopez-Beltran
    Scarpelli, Marina
    Principato, Giovanni
    Cascinu, Stefano
    Montironi, Rodolfo
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2015, 15 (09) : 1201 - 1210
  • [26] Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in Renal Cell Carcinoma
    Piva, Francesco
    Giulietti, Matteo
    Occhipinti, Giulia
    Santoni, Matteo
    Massari, Francesco
    Sotte, Valeria
    Iacovelli, Roberto
    Burattini, Luciano
    Santini, Daniele
    Montironi, Rodolfo
    Cascinu, Stefano
    Principato, Giovanni
    ONCOTARGET, 2015, 6 (31) : 32161 - 32168
  • [27] Exome Sequencing Shows BAP1 and PBRM1 Are Recurring Somatic Mutations in Biphenotypic Liver Carcinoma
    Sehn, J. K.
    Chapman, W. C.
    Tan, B. R.
    Brunt, E. M.
    MODERN PATHOLOGY, 2014, 27 : 428A - 428A
  • [28] Exome Sequencing Shows BAP1 and PBRM1 Are Recurring Somatic Mutations in Biphenotypic Liver Carcinoma
    Sehn, J. K.
    Chapman, W. C.
    Tan, B. R.
    Brunt, E. M.
    LABORATORY INVESTIGATION, 2014, 94 : 428A - 428A
  • [29] Angiogenic and T-effector subgroups identified by gene expression profiling (GEP) and propensity for PBRM1 and BAP1 alterations in clear cell renal cell carcinoma (ccRCC).
    Barata, Pedro C.
    Gulati, Shuchi
    Elliott, Andrew
    Rao, Arpit
    Hammers, Hans J.
    Quinn, David I.
    Gartrell, Benjamin Adam
    Zibelman, Matthew R.
    Wei Shuanzeng
    Geynisman, Daniel M.
    Zhang Tian
    Darabi, Sourat
    Dawson, Nancy Ann
    Hauke, Ralph J.
    Poorman, Kelsey Anne
    Nabhan, Chadi
    Ryan, Charles J.
    Heath, Elisabeth I.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [30] Exploration of Morphological Features of Clear Cell Renal Cell Carcinoma With PBRM1, SETD2, BAP1, or KDM5C Mutations
    Liu, Yang
    Li, Yunhao
    Xu, Haimin
    Zhou, Luting
    Yang, Xiaoqun
    Wang, Chaofu
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2023, 31 (08) : 1485 - 1494